Mumps: Complete Guide to Symptoms, Transmission, Complications, and Prevention

Mumps is an acute systemic viral illness caused by the mumps orthorubulavirus (Paramyxoviridae). Once a universal childhood disease, it is now rare in highly vaccinated populations but still causes outbreaks.

1. Causative Agent

Enveloped, single-stranded negative-sense RNA virus; one serotype (genotypes A–N; genotype G currently dominant globally).

2. Transmission

  • Respiratory droplets (cough, sneeze, talk).
  • Direct contact with saliva (sharing utensils, kissing).
  • Fomites (contaminated surfaces).
  • Most infectious: 2 days before to 5 days after parotitis onset.

3. Incubation Period

12–25 days (average 16–18 days).

4. Clinical Features

  • Parotitis: Unilateral/bilateral tender swelling below ear, obscuring jaw angle; pain on chewing/swallowing acidic foods.
  • Prodrome (1–2 days): Low-grade fever, malaise, myalgia, headache, anorexia.
  • Asymptomatic: 20–30% of infections (higher in vaccinated).

5. Complications

  • Orchitis (post-pubertal males, 15–30%), oophoritis (females, <5%).
  • Aseptic meningitis (up to 15%), encephalitis (<1%).
  • Pancreatitis (~4%), sensorineural hearing loss (~1/20,000).
  • Rare: myocarditis, nephritis, thyroiditis, arthritis.

6. Diagnosis

  • Clinical: Parotitis ≥2 days without other cause.
  • Lab confirmation: Buccal RT-PCR (preferred, within 3–7 days), IgM serology (limitations in vaccinated), paired IgG titers.

7. Treatment

  • Supportive only: analgesia, hydration, soft diet, compresses.
  • No specific antiviral.
  • Isolate 5 days after parotitis onset.

8. Immunity

  • Natural infection → lifelong immunity (rare reinfection).
  • Vaccine-induced immunity wanes over 10–15 years; breakthrough infections milder.

9. Vaccination

  • Live-attenuated Jeryl Lynn strain (in MMR/MMRV).
  • 2-dose series: 12–15 months, 4–6 years.
  • Effectiveness: ~88% (2 doses); third dose recommended in outbreaks.

10. Outbreak Control

  • High 2-dose coverage (>90%) is key.
  • Rapid case identification, isolation, contact tracing.
  • Third MMR dose for at-risk groups during sustained transmission.

Mumps remains a vaccine-preventable disease. Maintaining high immunization rates protects individuals and communities.

Baby Health - Related Articles